| Patents for C07D 403 - Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group (62,587) |
|---|
| 05/22/2009 | CA2705502A1 Phenylpyrazole derivatives |
| 05/22/2009 | CA2705391A1 Methods for identification of jak kinase interacting molecules and for the purification of jak kinases |
| 05/22/2009 | CA2705368A1 Azetidines as ep2 antagonists |
| 05/22/2009 | CA2704714A1 Pyridazinone derivatives as parp inhibitors |
| 05/22/2009 | CA2704628A1 Aryl- and heteroarylcarbonyl derivatives of benzomorphanes and related scaffolds, medicaments containing such compounds and their use |
| 05/22/2009 | CA2704599A1 4-pyrazolyl-n-arylpyrimidin-2-amines and 4-pyrazolyl-n-heteroarylpyrimidin-2-amines as janus kinase inhibitors |
| 05/21/2009 | US20090131497 Indoline-substituted pyrazoline derivatives, their preparation and use as medicaments |
| 05/21/2009 | US20090131494 Non-Nucleoside Reverse Transcriptase Inhibitors |
| 05/21/2009 | US20090131463 Novel compounds |
| 05/21/2009 | US20090131461 Quinoline and quinoxaline derivatives as inhibitors of kinase enzymatic activity |
| 05/21/2009 | US20090131454 New compounds 067 |
| 05/21/2009 | US20090131450 Use of pkc inhibitors in diabetic complications |
| 05/21/2009 | US20090131444 Aminopiperidine Quinolines and Their Azaisosteric Analogues with Antibacterial Activity |
| 05/21/2009 | US20090131438 Triazole derivative |
| 05/21/2009 | US20090131436 Pyrimidine Derivatives |
| 05/21/2009 | US20090131435 Heterocyclic inhibitors of mek and methods of use |
| 05/21/2009 | US20090131416 Substituted pyrazinyl amide compounds as modulators of the histamine h3 receptor |
| 05/21/2009 | US20090131401 Transcription factor modulating compounds and methods of use thereof |
| 05/21/2009 | US20090131398 Oxindole derivative as feeding control agent |
| 05/21/2009 | US20090131382 Treatment of rheumatoid arthritis using imatinib |
| 05/21/2009 | US20090130769 Novel Cross-Linkers For Obtaining Structure Information On Molecule Complexes |
| 05/21/2009 | US20090130225 Macrolides derivatives as antibacterial agents |
| 05/21/2009 | US20090130209 Novel Pyridazinone Derivatives |
| 05/21/2009 | US20090130117 Substituted Tetrazole Compounds and Uses Thereof |
| 05/21/2009 | US20090130097 Quinazolinone Compounds and Methods of Use Thereof |
| 05/21/2009 | US20090130024 Biocompatible N, N-Disubstituted Sulfonamide-Containing Fluorescent Dye Labels |
| 05/20/2009 | EP2060570A2 Azabicyclo(3.1.0) hexane derivatives useful as modulators of dopamine D3 receptors |
| 05/20/2009 | EP2060565A1 Novel bifunctional compounds which inhibit protein kinases and histone deacetylases |
| 05/20/2009 | EP2060258A1 Use of CRTH2 antagonist compounds in therapy |
| 05/20/2009 | EP2059511A1 Sulphoximides as protein kinase inhibitors |
| 05/20/2009 | EP2059502A2 Proline urea ccr1 antagonists for the treatment of autoimmune diseases or inflammation |
| 05/20/2009 | EP1534686B1 Nf-kb inhibitors and uses thereof |
| 05/20/2009 | CN101437814A Benzazepine derivatives as monoamine reuptake inhibitors |
| 05/20/2009 | CN101437813A Mglur5 modulators III |
| 05/20/2009 | CN101437803A Dibenzyl amine derivatives as CETP inhibitors |
| 05/20/2009 | CN100488952C 5-phenyl pyridine, its preparation method and intermediate product and uses in controlling harmful fungus |
| 05/20/2009 | CN100488948C N-substituted indole-3-acetaldehyde amide compound with anti-asthma, anti-amaphylactic and immunosupression/immunoregulation action |
| 05/20/2009 | CN100488506C 5-membered heterocycle derivatives, production thereof and use as medicaments |
| 05/19/2009 | US7534897 Indole arylsulfonaimide compounds exhibiting PGD 2 receptor antagonism |
| 05/19/2009 | US7534894 2-[(4'-{[5-(2-chlorophenyl)-2-(trifluoromethyl)-3-furoyl]amino}-1,1'-biphenyl-3-yl)oxy]-3-phenylpropanoic acid ; thrombosis, atrial fibrillation, pulmonary fibrosis, stroke, myocardial ischemia, atherosclerotic plaque formation, chronic obstructive pulmonary disease, or renal fibrosis |
| 05/19/2009 | US7534808 Indolylmaleimide derivatives |
| 05/19/2009 | US7534805 Imidazole derivatives, their preparation and their use as medicaments |
| 05/19/2009 | US7534798 Vanilloid receptor ligands and their use in treatments |
| 05/19/2009 | US7534794 Certain arylaliphatic and heteroaryl-aliphatic piperazinyl pyrazines and their use in the treatment of serotonin-related diseases |
| 05/19/2009 | US7534792 Pyrrolotriazine kinase inhibitors |
| 05/19/2009 | US7534421 Water solubility; photostability; sunscreen agents; ultraviolet radiation B and A absorbers |
| 05/19/2009 | CA2368059C Bicyclic heterocycles, pharmaceutical compositions containing these compounds, their use and processes for preparing them |
| 05/19/2009 | CA2364801C Pyridazin-3-one derivatives and medicines containing the same |
| 05/19/2009 | CA2336634C Antiviral macrocyclic compounds |
| 05/14/2009 | WO2009061761A2 Fungicidal heterocyclic amines |
| 05/14/2009 | WO2009061652A1 Compounds which modulate the cb2 receptor |
| 05/14/2009 | WO2009061498A1 CYCLIC UREA INHIBITORS OF 11β -HYDROXYSTEROID DEHYDROGENASE 1 |
| 05/14/2009 | WO2009061271A1 Some 2-pyrazinone derivatives and their use as inhibitors of neutrophile elastase |
| 05/14/2009 | WO2009060742A1 Organic electroluminescent device, display device, and illuminating device |
| 05/14/2009 | WO2009060215A1 Polyamides |
| 05/14/2009 | WO2009060208A1 Pyrrolobenzodiazepines |
| 05/14/2009 | WO2009031040A3 Compounds with anti-cancer activity |
| 05/14/2009 | WO2009027601A3 Pyrazole 3,5 carboxylate derivatives preparation and therapeutic application thereof |
| 05/14/2009 | WO2008118823A3 Compositions and methods for inhibition of the jak pathway |
| 05/14/2009 | WO2008067378A3 Preparation and utility of substituted phenyltetrazoles |
| 05/14/2009 | WO2008049123A8 2,4-pyrimidinediamine derivatives as inhibitors of jak kinases for the treatment of autoimmune diseases |
| 05/14/2009 | WO2006012624A3 Mechanism-based crosslinkers |
| 05/14/2009 | US20090124814 Process for preparing telmisartan |
| 05/14/2009 | US20090124677 couplilng reaction of 2-(1H-tetrazol-5-yl)phenylboronic acid with 2-butyl-3-(4'-iodobenzyl)-1,3-diazaspiro[4,4]non-1-en-4-one in a solvent e.g. tetrahydrofuran, in presence of inorganic or organic bases ( triethyamine, potassium carbonate etc) with a palladium catalyst containing phosphine ligand |
| 05/14/2009 | US20090124668 Cyclic derivatives as modulators of chemokine receptor activity |
| 05/14/2009 | US20090124667 Novel Dual-Use Peptidase Inhibitors as Prodrugs for a Therapy of Inflammatory and Other Diseases |
| 05/14/2009 | US20090124647 Indole Derivatives as Antitumoral Compounds |
| 05/14/2009 | US20090124641 Mitotic Kinesin Inhibitors |
| 05/14/2009 | US20090124634 Novel dipodazine compounds and applications |
| 05/14/2009 | US20090124629 3-(1,2,4-triazol-3ylalkyl) azabriclo (3.1.0) hexane derivatives as modulators of dopamine d3 receptors |
| 05/14/2009 | US20090124625 Novel alkynyl derivatives as modulators of metatropic glutamate receptors |
| 05/14/2009 | US20090124621 Pyrazole derivatives as kinase inhibitors |
| 05/14/2009 | US20090124616 7-nonsubstituted indole mcl-1 inhibitors |
| 05/14/2009 | US20090124615 3-[((1R)-1-{2-Chloro-3-[(1-methyl-4-piperidinyl)oxy]phenyl}ethyl)oxy]-5-[5-(1-methyl-1H-pyrazol-4-yl)-1H-benzimidazol-1-yl]-2-thiophenecarboxamide; polo like kinase enzyme inhibitors; anticarcinogenic agents for treating cancer |
| 05/14/2009 | US20090124604 4-oxoquinazolin-3-yl benzamide derivatives for the treatment of cytokine diseases |
| 05/14/2009 | US20090124576 Triazine Derivatives |
| 05/14/2009 | US20090124559 Soft Protease Inhibitors and Pro-Soft Forms Thereof |
| 05/14/2009 | US20090123686 Optical recording material and cyanine compound |
| 05/14/2009 | US20090123480 Bivalent smac mimetics and the uses thereof |
| 05/14/2009 | US20090123423 Hydroxyamic analogs as hepatitis c virus serine protease inhibitor |
| 05/14/2009 | US20090121622 New organic compound and organic light emitting device using the same |
| 05/14/2009 | US20090121617 Electronic devices made with electron transport and/or anti-quenching layers |
| 05/14/2009 | CA2704684A1 Compounds which modulate the cb2 receptor |
| 05/14/2009 | CA2704222A1 Cyclic urea inhibitors of 11.beta.-hydroxysteroid dehydrogenase 1 |
| 05/14/2009 | CA2703996A1 Some 2-pyrazinone derivatives and their use as inhibitors of neutrophile elastase |
| 05/13/2009 | EP2058307A1 Methods for the identification of JAK kinase interacting molecules and for the purification of JAK kinases |
| 05/13/2009 | EP2057153A1 (3-aryl-piperazin-1-yl), (2-aryl-morpholin-4-yl) and (2-aryl- thiomorpholin-4-yl) derivatives of 6,7-dialkoxyquinazoline, 6,7- dialkoxyphtalazine and 6,7-dialkoxyisoquinoline |
| 05/13/2009 | EP2057147A1 Pyrimidine derivatives |
| 05/13/2009 | EP2057146A1 Compounds and compositions as protein kinase inhibitors |
| 05/13/2009 | EP2057141A1 Pyrimidone compounds as gsk-3 inhibitors |
| 05/13/2009 | EP2057140A1 Morpholino pyrimidine derivatives useful in the treatment of proliferative disorders |
| 05/13/2009 | EP2057124A2 Compounds and compositions as itpkb inhibitors |
| 05/13/2009 | EP1926723B1 Azabicyclo (3,1,0) hexan derivatives useful as modulators of dopamine d3 rceptors |
| 05/13/2009 | EP1587795B1 N- (1-benzyl-2-oxo-2- (1-piperazinyl) ethyl) -1-piperidincarboxamid-derivatives and related compounds use as cgrp-antagonists for treating a headache |
| 05/13/2009 | EP1397356B1 Substituted naphthyl indole derivatives as inhibitors of plasminogen activator inhibitor type-1 (pai-1) |
| 05/13/2009 | EP1305026B1 Barbituric acid analogs as therapeutic agents |
| 05/13/2009 | EP1252140B1 Pyrrolecarboxamides and pyrrolethioamides as fungicides |
| 05/13/2009 | EP0934311B1 New heterocyclylmethyl-substituted pyrazol derivates |
| 05/13/2009 | CN101432278A Diketo-piperazine and piperidine derivatives as antiviral agents |
| 05/13/2009 | CN101432269A 1-sulfonylindazolylamine and -amide derivatives as 5-hydroxytryptamine-6 ligands |